Ethanediamide, N1-(5-chloro-2-pyridinyl)-N2-[(1R,2S,4R)-4-[(dimethylamino)carbonyl]-2-[[(4,5,6,7-tetrahydro-5-methylthiazolo[5,4-c]pyridin-2-yl)carbonyl]amino]cyclohexyl]-
|
|
|
- CAS-Nr.
- 1255529-23-7
- Englisch Name:
- Ethanediamide, N1-(5-chloro-2-pyridinyl)-N2-[(1R,2S,4R)-4-[(dimethylamino)carbonyl]-2-[[(4,5,6,7-tetrahydro-5-methylthiazolo[5,4-c]pyridin-2-yl)carbonyl]amino]cyclohexyl]-
- Synonyma:
- Edoxaban-9;Ent-Edoxaban;Enantiomer(RSR);Edoxaban iMpurity I;Edoxaban RSR Isomer;Edoxaban Impurity 46;Edoxaban Isomer (RSR);Edoxaban iMpurities 9;Yidu Saban Impurity I;EthanediaMide iMpurity I
- CBNumber:
- CB72570333
- Summenformel:
- C24H30ClN7O4S
- Molgewicht:
- 548.06
- MOL-Datei:
- 1255529-23-7.mol
|
Ethanediamide, N1-(5-chloro-2-pyridinyl)-N2-[(1R,2S,4R)-4-[(dimethylamino)carbonyl]-2-[[(4,5,6,7-tetrahydro-5-methylthiazolo[5,4-c]pyridin-2-yl)carbonyl]amino]cyclohexyl]- Eigenschaften
- Dichte
- 1.43±0.1 g/cm3(Predicted)
- pka
- 9.46±0.70(Predicted)
Sicherheit
Ethanediamide, N1-(5-chloro-2-pyridinyl)-N2-[(1R,2S,4R)-4-[(dimethylamino)carbonyl]-2-[[(4,5,6,7-tetrahydro-5-methylthiazolo[5,4-c]pyridin-2-yl)carbonyl]amino]cyclohexyl]- Chemische Eigenschaften,Einsatz,Produktion Methoden
Verwenden
Ent-Edoxaban is the enantiomer of Edoxaban (E555520) which is an anticoagulant drug which acts as a direct factor Xa inhibitor. Ent-Edoxaban serves as a useful pharmaceutical standard for inspecting impurities of similar structure.
Ethanediamide, N1-(5-chloro-2-pyridinyl)-N2-[(1R,2S,4R)-4-[(dimethylamino)carbonyl]-2-[[(4,5,6,7-tetrahydro-5-methylthiazolo[5,4-c]pyridin-2-yl)carbonyl]amino]cyclohexyl]- Upstream-Materialien And Downstream Produkte
Upstream-Materialien
Downstream Produkte
Ethanediamide, N1-(5-chloro-2-pyridinyl)-N2-[(1R,2S,4R)-4-[(dimethylamino)carbonyl]-2-[[(4,5,6,7-tetrahydro-5-methylthiazolo[5,4-c]pyridin-2-yl)carbonyl]amino]cyclohexyl]- Anbieter Lieferant Produzent Hersteller Vertrieb H?ndler.
Global( 83)Lieferanten
1255529-23-7()Verwandte Suche:
- EthanediaMide, N1-(5-chloro-2-pyridinyl)-N2-[(1R,2S,4R)-4-[(diMethylaMino)carbonyl]-2-[[(4,5,6,7-tetrahydro-5-Methylthiazolo[5,4-c]pyridin-2-yl)carbonyl]aMino]cyclohexyl]-
- Edoxaban iMpurity I
- N1-(5-chloropyridin-2-yl)-N2-((1R,2S,4R)-4-(diMethylcarbaMoyl)-2-(5-Methyl-4,5,6,7-tetrahydrothiazolo[5,4-c]pyridine-2-carboxaMido)cyclohexyl)oxalaMide
- N1-(5-chloro-2-pyridinyl)-N2-[(1R,2S,4R)-4-[(diMethylaMino)carbonyl]-2-[[(4,5,6,7-tetrahydro-5-Methylthiazolo[5,4-c]pyridin-2-yl)carbonyl]aMino]cyclohexyl]- EthanediaMide
- Edoxaban Isomer (RSR)
- N-(5-Chloropyridin-2-yl)-N'-[(1R,2S,4R)-4-[(dimethylamino)carbonyl]-2-[[(5-methyl-4,5,6,7-tetrahydrothiazolo[5,4-c]pyridin-2-yl)carbonyl]amino]cyclohexyl]ethanediamide
- Enantiomer(RSR)
- Edoxaban impurity 5/Ent-Edoxaban/Edoxaban RSR Isomer/N1-(5-chloropyridin-2-yl)-N2-((1R,2S,4R)-4-(dimethylcarbamoyl)-2-(5-methyl-4,5,6,7-tetrahydrothiazolo[5,4-c]pyridine-2-carboxamido)cyclohexyl)oxalamide
- Edoxaban iMpurities 9
- Edoxaban-9
- (5-chloropyridin-2-yl)-N2-((1R,2S,4R)-4-(dimethylcarbamoyl)-2-(5-methyl-4,5,6,7-tetrahydrothiazolo[5,4-c]pyridine-2-carboxamido)cyclohexyl)oxalamide
- Edoxaban RSR Isomer
- Edoxaban impurity 5/Edoxaban RSR Isomer
- N1-(5-chloropyridin-2-yl)-N2-((1R,2S,4R)-4-[(dimethylamino)carbonyl]-2-{[(5-methyl-4,5,6,7-tetrahydrothiazolo[5,4-c]pyridin-2-yl)carbonyl]amino}cyclohexyl)ethanediamide
- Edoxaban Impurity 46
- Edoxaban RSR Isomer Impurity
- Ent-Edoxaban
- EthanediaMide, N1-(5-chlo… impurity
- N1-(5-chloropyridin-2-yl)-N2-((1R,2S,4R)-4-(dimethylcarbamoyl)-2-(5-methyl-4,5,6,7-tetrahydrothiazolo[5,4-c]pyridine-2-carboxamido)cyclohexyl)oxalamid
- Ethanediamide, N1-(5-chloro-2-pyridinyl)-N2-[(1R,2S,4R)-4-[(...
- N-(5-chloro-2-pyridyl)-N'-[(1R,2S,4R)-4-(dimethylcarbamoyl)-2-[(5-methyl-6,7-dihydro-4H-thiazolo[5,4-c]pyridine-2-carbonyl)amino]cyclohexyl]oxamide
- Yidu Saban Impurity I
- Edoxaban Impurity 46 (1R,2S,4R)
- N-(5-chloro-2-pyridyl)-N'-[(1R,2S,4R)-4-(dimethylcarbamoyl)-2-[(5-methyl-6,7-dihydro-4H-thiazolo[5,4-c]pyridine-2-carbonyl)amino]cyclohexyl]oxamide
- EthanediaMide iMpurity I
- 1255529-23-7
